Is KMB a good stock to buy? We came across a bullish thesis on Kimberly-Clark Corporation on Investing Lawyer’s Substack. In this article, we will summarize the bulls’ thesis on KMB. Kimberly-Clark Corporation's share was trading at $98.25 as of April 27th. KMB’s trailing and forward P/E were 20.22 and 13.11 respectively according to Yahoo Finance.
Kimberly-Clark Corporation is a global consumer products leader behind essential everyday brands such as Huggies, Kleenex, and Scott, positioning the company as a resilient operator within the defensive household and personal care segment. The company’s dividend profile remains a central pillar of its investment appeal, with a forward payout ratio of 72.67%, approximately 3.35% dividend growth over the past five years, and an exceptional 52-year track record of consecutive dividend increases, underscoring both consistency and long-term capital return discipline.
While the payout ratio suggests moderate headroom rather than aggressive expansion, the strength and stability of Kimberly-Clark’s cash flow generation alleviate concerns around sustainability, supported by the non-discretionary nature of its product portfolio and steady global demand. This resilience becomes particularly valuable in uncertain macroeconomic environments, where consumer staples companies tend to outperform due to inelastic demand characteristics.
Kimberly-Clark’s scale, brand equity, and distribution advantages further reinforce its ability to maintain pricing power and margins, even amid input cost fluctuations. As a result, the company stands out as a compelling recession-resistant investment, offering a combination of dependable income, defensive positioning, and gradual growth.
Even with a relatively modest yield, the durability of earnings and cash flows, alongside disciplined capital allocation, supports a favorable long-term outlook. For investors seeking stability with consistent shareholder returns, Kimberly-Clark represents a high-quality compounder capable of delivering reliable performance across economic cycles while preserving downside protection.
Previously, we covered a bullish thesis on Colgate-Palmolive Company (CL) by Kontra in October 2024, which highlighted the company’s positioning as a quality compounder driven by pricing power, premiumization, and emerging market exposure. CL’s stock price has depreciated by approximately 16.21% since our coverage. Investing Lawyer shares a similar view but emphasizes dividend durability, cash flow stability, and recession-resistant demand.
Kimberly-Clark Corporation is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 56 hedge fund portfolios held KMB at the end of the fourth quarter which was 42 in the previous quarter. While we acknowledge the risk and potential of KMB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than KMB and that has 10,000% upside potential, check out our report about this cheapest AI stock.